1. Home
  2. SAIA vs RGEN Comparison

SAIA vs RGEN Comparison

Compare SAIA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Saia Inc.

SAIA

Saia Inc.

HOLD

Current Price

$331.26

Market Cap

9.1B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$110.07

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIA
RGEN
Founded
1924
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.1B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
SAIA
RGEN
Price
$331.26
$110.07
Analyst Decision
Buy
Buy
Analyst Count
19
11
Target Price
$378.56
$175.64
AVG Volume (30 Days)
553.5K
834.9K
Earning Date
04-24-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
9.52
0.86
Revenue
$3,234,286,000.00
$141,236,000.00
Revenue This Year
$6.30
$14.31
Revenue Next Year
$9.37
$14.41
P/E Ratio
$35.10
$128.20
Revenue Growth
0.79
35.10
52 Week Low
$248.37
$102.97
52 Week High
$430.11
$175.77

Technical Indicators

Market Signals
Indicator
SAIA
RGEN
Relative Strength Index (RSI) 41.87 30.20
Support Level $316.05 N/A
Resistance Level $364.86 $132.51
Average True Range (ATR) 14.24 4.68
MACD 0.05 0.43
Stochastic Oscillator 33.49 2.57

Price Performance

Historical Comparison
SAIA
RGEN

About SAIA Saia Inc.

Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: